Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 2
2010 1
2011 2
2012 1
2013 1
2019 1
2021 1
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

8 results
Results by year
Filters applied: . Clear all
Page 1
Medication Safety in Two Intensive Care Units of a Community Teaching Hospital After Electronic Health Record Implementation: Sociotechnical and Human Factors Engineering Considerations.
Carayon P, Wetterneck TB, Cartmill R, Blosky MA, Brown R, Hoonakker P, Kim R, Kukreja S, Johnson M, Paris BL, Wood KE, Walker JM. Carayon P, et al. Among authors: paris bl. J Patient Saf. 2021 Aug 1;17(5):e429-e439. doi: 10.1097/PTS.0000000000000358. J Patient Saf. 2021. PMID: 28248749
System-dependent outcomes during the evaluation of drug candidates as inhibitors of cytochrome P450 (CYP) and uridine diphosphate glucuronosyltransferase (UGT) enzymes: human hepatocytes versus liver microsomes versus recombinant enzymes.
Parkinson A, Kazmi F, Buckley DB, Yerino P, Ogilvie BW, Paris BL. Parkinson A, et al. Among authors: paris bl. Drug Metab Pharmacokinet. 2010;25(1):16-27. doi: 10.2133/dmpk.25.16. Drug Metab Pharmacokinet. 2010. PMID: 20208386 Free article. Review.
An in vitro evaluation of the victim and perpetrator potential of the anticancer agent laromustine (VNP40101M), based on reaction phenotyping and inhibition and induction of cytochrome P450 enzymes.
Nassar AE, King I, Paris BL, Haupt L, Ndikum-Moffor F, Campbell R, Usuki E, Skibbe J, Brobst D, Ogilvie BW, Parkinson A. Nassar AE, et al. Among authors: paris bl. Drug Metab Dispos. 2009 Sep;37(9):1922-30. doi: 10.1124/dmd.109.027516. Epub 2009 Jun 11. Drug Metab Dispos. 2009. PMID: 19520774